Drug Testing And Analysis 2011-01-01

Some new psychoactive substances: precursor chemicals and synthesis-driven end-products.

Michael Collins

Index: Drug Test. Anal. 3(7-8) , 404-16, (2011)

Full Text: HTML

Abstract

This paper describes some of the new classes of 'designer drugs' being encountered today by forensic scientists and law enforcement agencies in Europe, the United States, and Australia. In particular, it concentrates on new cathinone derivatives, the tryptamines, new-generation phenethylamines, and some of the synthetic cannabinoids. The synthetic approaches towards many of these designer drugs including a discussion of the chemical precursors used in the syntheses are presented. Many of today's so-called designer drugs exist as a result of legitimate research into medical conditions and the natural product chemistry. A link between synthetic approaches published in the open scientific and medical literature and the exploitation of this research by clandestine manufacture of drugs for illicit purposes is drawn.Copyright © 2011 John Wiley & Sons, Ltd.

Related Compounds

  • 2-phenylethanamini...
  • 2-Phenylethanamine

Related Articles:

A beating heart cell model to predict cardiotoxicity: effects of the dietary supplement ingredients higenamine, phenylethylamine, ephedrine and caffeine.

2015-04-01

[Food Chem. Toxicol. 78 , 207-13, (2015)]

Automated derivatization and fluorimetric determination of biogenic amines in milk by zone fluidics coupled to liquid chromatography.

2014-08-22

[J. Chromatogr. A. 1356 , 272-6, (2014)]

Isolation and identification of an allelopathic phenylethylamine in rice.

2014-12-01

[Phytochemistry 108 , 109-21, (2014)]

Direct benzylic metalation of a phenethylamine derivative: potassium as the key to both generation and stabilization of a labile anion.

2012-11-07

[Chem. Commun. (Camb.) 48(86) , 10612-4, (2012)]

Vasoconstrictor and vasodilator responses to tryptamine of rat-isolated perfused mesentery: comparison with tyramine and β-phenylethylamine.

2012-04-01

[Br. J. Pharmacol. 165(7) , 2191-202, (2012)]

More Articles...